Leriglitazone (hydrochloride), CAS [[146062-46-6]]

Produktübersicht

• Artikelname: Leriglitazone (hydrochloride), CAS [[146062-46-6]]
• Artikelnummer: MCE-HY-117727A
• Hersteller Artikelnummer: HY-117727A
• Alternativnummer: MCE-HY-117727A-50MG,MCE-HY-117727A-25MG,MCE-HY-117727A-5MG,MCE-HY-117727A-10MG,MCE-HY-117727A-100MG,MCE-HY-117727A-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: MIN-102 (hydrochloride), Hydroxypioglitazone (hydrochloride)

Produktbeschreibung

Leriglitazone (MIN-102, Hydroxypioglitazone) hydrochloride is an orally active and a BBB-penetrable PPARgamma agonist with an EC50 of 9 µM. Leriglitazone hydrochloride, as a regulator of mitochondrial function, has neuroprotective, anti-inflammatory and antioxidant effects. Leriglitazone hydrochloride can be used in the study of neuroinflammatory and neurodegenerative diseases[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 408.90
• Reinheit: 99.64
• CAS Nummer: [146062-46-6]
• Formel: C19H21ClN2O4S
• Target-Kategorie: PPAR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound